Since then, the pair have partnered to combine data from Roche's Accu-Chek Connect blood glucose meter into the mySugr app. The companies expanded their relationship earlier this year ...

Lipoprotein(a) has long been recognized as a critical marker for people at risk of cardiovascular disease. However, the health care industry has lacked the tools to tackle the problem.

“Susvimo presents a unique, convenient treatment alternative to routine eye injections for people with a potentially blinding diabetic eye condition,” said Levi Garraway, MD, PhD, Roche's Chief ... in ...

Basel, 04 February 2025 - Roche (SIX: RO, ROG ... macular edema (DME), a leading cause of vision loss in adults with diabetes, affecting more than 29 million adults worldwide.

11,12 The number of people with DME is expected to grow as the prevalence of diabetes increases ... formation of new blood vessels and the leakiness of the vessels.15 About Roche in ...

Basel, 04 February 2025 - Roche (SIX: RO, ROG; OTCQX ... for the treatment of diabetic macular edema (DME), a leading cause of vision loss in adults with diabetes, affecting more than 29 million ...

a member of the Roche Group. Genentech retains commercial rights in the United States and Novartis has exclusive commercial rights for the rest of the world. [1] Diep TM, et al. Risk factors ...

Purpose: The precision and accuracy of two blood glucose meters were evaluated using finger and forearm blood samples. Methods: Duplicate blood glucose measurements on the same forearm and finger ...

Is there a benefit for healthy people to track their blood sugar? Measuring blood sugar has joined sleep and exercise tracking as wellness trends, with some longevity experts claiming that ...